Back
Royal Gold, Inc. Vs. Axsome Therapeutics, Inc. Industry Stock Comparison
Buy
69
RGLD
Royal Gold, Inc.
Last Price:
$222.18
Seasonality Move:
11.85%
Buy
75
AXSM
Axsome Therapeutics, Inc.
Last Price:
$182.74
Seasonality Move:
22.61%
Buy
69
Royal Gold, Inc. (RGLD)
is a Buy
Is Royal Gold, Inc. a Buy, Sell or Hold?
-
The current Royal Gold, Inc. [RGLD] share price is $222.29. The Score for RGLD is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
RGLD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Axsome Therapeutics, Inc. (AXSM)
is a Buy
Is Axsome Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Axsome Therapeutics, Inc. [AXSM] share price is $182.64. The Score for AXSM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGLD Stock Price Chart
What is Royal Gold, Inc.'s stock price today?
-
The Royal Gold, Inc. share price today is $222.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLD is experiencing selling pressure, which indicates risk of future bearish movement.
AXSM Stock Price Chart
What is Axsome Therapeutics, Inc.'s stock price today?
-
The Axsome Therapeutics, Inc. share price today is $182.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 62.39 | Buy |
| Relative Strength Index (14 RSI): | 59.69 | Buy |
| Chaikin Money Flow: | -345691 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (201.8 - 227.3) | Buy |
| Bollinger Bands (100): | (176.22 - 209.34) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.73 | Buy |
| Relative Strength Index (14 RSI): | 79.74 | Buy |
| Chaikin Money Flow: | 2638953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.49 - 157.75) | Buy |
| Bollinger Bands (100): | (116.98 - 146.48) | Buy |
RGLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 228.95 | Sell |
| 20-day SMA: | 218.26 | Buy |
| 50-day SMA: | 198.12 | Buy |
| 200-day SMA: | 181.63 | Buy |
| 8-day EMA: | 208.59 | Buy |
| 20-day EMA: | 143.95 | Buy |
| 50-day EMA: | 75.09 | Buy |
| 200-day EMA: | 21.67 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 156.17 | Buy |
| 20-day SMA: | 151.07 | Buy |
| 50-day SMA: | 144.32 | Buy |
| 200-day SMA: | 119.69 | Buy |
| 8-day EMA: | 157.9 | Buy |
| 20-day EMA: | 152.42 | Buy |
| 50-day EMA: | 144.44 | Buy |
| 200-day EMA: | 123.72 | Buy |
Royal Gold, Inc. Earnings Growth & RGLD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.38 per share, and an increase next year of $0.73 per share.
Axsome Therapeutics, Inc. Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.11 per share, and an increase next year of $5.92 per share.
Royal Gold, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||